Literature DB >> 89121

Comparison of spontaneous and experimentally induced canine prostatic hyperplasia.

D P DeKlerk, D S Coffey, L L Ewing, I R McDermott, W G Reiner, C H Robinson, W W Scott, J D Strandberg, P Talalay, P C Walsh, L G Wheaton, B R Zirkin.   

Abstract

Spontaneous prostatic hyperplasia in the beagle appears to progress with age from a glandular to a cystic histological appearance. Prostatic hyperplasia can be induced in young beagles with intact testes by treatment for 4 mo with either dihydrotestosterone or 5 alpha-androstane-3 alpha, 17 beta-diol, alone, or with either of these steroids in combination with 17 beta-estradiol. In contrast, the induction of prostatic hyperplasia in young castrated beagles, in which the gland had been allowed to involute for 1 mo, requires the administration of both 17 beta-estradiol and either 5 alpha-androstane-3 alpha, 17 beta-diol or dihydrotestosterone. Testosterone and 17 beta-estradiol, either singly or in combination, did not produce the hyperplastic condition in intact or castrated beagles. The experimentally induced prostatic hyperplasia is identical in pathology to the glandular hyperplasia that occurs naturally in the aging dog with intact testes. However, cystic hyperplasia was not produced by any of the treatments tested in young animals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 89121      PMCID: PMC372190          DOI: 10.1172/JCI109532

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  A research for inhibitors of prostate growth stimulators.

Authors:  W W SCOTT; W J HOPKINS; W M LUCAS; C TESAR
Journal:  J Urol       Date:  1957-04       Impact factor: 7.450

2.  Parenchymatous hypertrophy of the canine prostate gland.

Authors:  O A BERG
Journal:  Acta Endocrinol (Copenh)       Date:  1958-02

3.  Studies on the canine prostate gland. I. Factors influencing its size and weight.

Authors:  J D O'SHEA
Journal:  J Comp Pathol       Date:  1962-07       Impact factor: 1.311

4.  Effects of a novel nonsteroidal antiandrogen on canine prostatic hyperplasia.

Authors:  R O Neri; M Monahan
Journal:  Invest Urol       Date:  1972-09

5.  Comparison of the metabolites formed in rat prostate following the in vivo administration of seven natural androgens.

Authors:  N Bruchovsky
Journal:  Endocrinology       Date:  1971-11       Impact factor: 4.736

6.  Androgen metabolism in the hypertrophic prostate.

Authors:  J D Wilson; R E Gloyna; P K Siiteri
Journal:  J Steroid Biochem       Date:  1975 Mar-Apr       Impact factor: 4.292

7.  Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.

Authors:  R E Gloyna; P K Siiteri; J D Wilson
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

8.  Studies on the mechanism of 3 alpha-androstanediol-induced growth of the dog prostate.

Authors:  G H Jacobi; R J Moore; J D Wilson
Journal:  Endocrinology       Date:  1978-06       Impact factor: 4.736

9.  Morphogenesis of nodular hyperplasia--prostate.

Authors:  B K Pradhan; K Chandra
Journal:  J Urol       Date:  1975-02       Impact factor: 7.450

10.  Quantitative studies of prostatic secretion. III. Simultaneous measurement of size and secretion of the canine prostate and the interaction of androgenic and estrogenic substances thereon.

Authors:  C HUGGINS; J L SOMMER
Journal:  J Exp Med       Date:  1953-05       Impact factor: 14.307

View more
  29 in total

Review 1.  Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor.

Authors:  Trevor M Penning; David R Bauman; Yi Jin; Tea Lanisik Rizner
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

Review 2.  The role of estrogens and estrogen receptors in normal prostate growth and disease.

Authors:  Gail S Prins; Kenneth S Korach
Journal:  Steroids       Date:  2007-11-12       Impact factor: 2.668

Review 3.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 4.  Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.

Authors:  LaTayia Aaron; Omar E Franco; Simon W Hayward
Journal:  Urol Clin North Am       Date:  2016-08       Impact factor: 2.241

5.  Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.

Authors:  Erin M McAuley; Devkumar Mustafi; Brian W Simons; Rebecca Valek; Marta Zamora; Erica Markiewicz; Sophia Lamperis; Anthony Williams; Brian B Roman; Chad Vezina; Greg Karczmar; Aytekin Oto; Donald J Vander Griend
Journal:  Am J Pathol       Date:  2017-08-18       Impact factor: 4.307

Review 6.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

7.  Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses.

Authors:  F S vom Saal; B G Timms; M M Montano; P Palanza; K A Thayer; S C Nagel; M D Dhar; V K Ganjam; S Parmigiani; W V Welshons
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

8.  Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs.

Authors:  T M Penning; I Mukharji; S Barrows; P Talalay
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

9.  Estrogenic action of commonly used fragrant agent citral induces prostatic hyperplasia.

Authors:  A A Geldof; C Engel; B R Rao
Journal:  Urol Res       Date:  1992

Review 10.  Pre-receptor regulation of the androgen receptor.

Authors:  Trevor M Penning; Yi Jin; Tea Lanisnik Rizner; David R Bauman
Journal:  Mol Cell Endocrinol       Date:  2007-10-22       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.